Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1974-06-17
1977-01-11
Meyers, Albert T.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424 35, 424362, A61K 2902, A61K 922
Patent
active
040027317
ABSTRACT:
Divided doses or sustained release formulations of sodium tyropanoate upon oral administration provide adequate gallbladder visualization with substantially lower blood levels than are obtained with conventional single dose administration.
REFERENCES:
patent: 1815902 (1931-07-01), Ellzey
patent: 2436270 (1948-02-01), Schwenk et al.
patent: 2790748 (1957-04-01), Papa et al.
patent: 2801203 (1957-07-01), Leb et al.
patent: 2895988 (1959-07-01), Archer et al.
patent: 3042715 (1962-07-01), Obendorf et al.
patent: 3133863 (1964-05-01), Tansey
patent: 3144479 (1964-08-01), Obendorf
patent: 3184386 (1965-05-01), Stephenson
patent: 3226431 (1965-12-01), Felder et al.
Koehler et al., Radiology, vol. 108, pp. 517-519, Sept. 1973.
Fischer et al., Investigative Radiology, vol. 9, pp. 24-31 (No. 1, Jan. - Feb. 1974).
Clarke Vera C.
Johnson Thomas L.
Meyers Albert T.
Sterling Drug Inc.
Wyatt B. Woodrow
LandOfFree
Diagnostic process using sodium tyropanoate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnostic process using sodium tyropanoate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic process using sodium tyropanoate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1743767